Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Cell/Gene Tx channel feed
Caribou lays off 32% of staff, cuts lupus cell therapy program before first patient
5 weeks ago
People
R&D
Ayrmid misses deadline for detailed offer to top private equity bid for bluebird
Last month
Deals
Siddhartha Mukherjee’s cell therapy startup narrows focus as staff shrinks
Last month
R&D
Verve unveils early data from second attempt at heart disease gene editing
Last month
R&D
Cartesian reveals long-term mid-stage data for cell therapy in myasthenia gravis
Last month
R&D
Cell and gene therapy CDMO AmplifyBio shuts down over 'scarcity' of funding
Last month
Manufacturing
Exclusive: Neurona bags $102M to treat epilepsy with cell therapy
Last month
Financing
Startups
FDA cuts stir buyer’s remorse for some biopharma leaders, once excited by Trump
Last month
Pharma
FDA+
Atsena gets Bain's support in $150M Series C to thwart blindness with gene therapy
Last month
Financing
Startups
New CDMO emerges, acquires cell and gene manufacturer Landmark Bio
Last month
Deals
Manufacturing
DC court sides with HHS in Vertex's fertility program fight
Last month
Pharma
Law
Tenaya to lay off about one-third of staff, reveals heart gene therapy data
Last month
R&D
Vertex’s second-generation diabetes cell therapy fails early-stage study
Last month
R&D
ElevateBio trims workforce by 17%
2 months ago
People
Startups
Stem cell company bit.bio cuts quarter of staff, drops therapeutics focus
2 months ago
People
Sixteen-year-old dies after receiving Sarepta’s Duchenne gene therapy
2 months ago
Pharma
Orca Bio's T cell therapy may help blood cancer patients avoid transplant issues
2 months ago
R&D
AstraZeneca to buy cell therapy startup for $425M upfront
2 months ago
Deals
RFK Jr. convened roundtable around ways to reduce stem cell regulation
2 months ago
Pharma
MeiraGTx teams with cryptic AI startup, co-founded by Eric Schmidt, to advance Parkinson's gene therapy
2 months ago
Deals
AI
Legend to double Carvykti production as it targets blockbuster status
2 months ago
Pharma
Manufacturing
Bristol Myers buys out cell therapy partner 2seventy bio
2 months ago
Deals
Pharma
Beam shares promising first clinical data on gene editing treatment for a lung and liver disease
2 months ago
R&D
How bluebird's buyout offer went from $100M upfront to $29M
2 months ago
Deals
First page
Previous page
1
2
3
4
5
Next page
Last page
